Press-release for stocks publishing date 2021 - 11 - 01 for NVAX

Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 11 - 01 symbols : NVAX

save search

Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency
Published: 2021-11-01 (Crawled : 11:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M

|

Health Technology

| -97.33% | O: 7.21% H: 8.92% C: 8.08%
covid europe vaccine submission

Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
Published: 2021-11-01 (Crawled : 11:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M

|

| -96.64% | O: 1.5% H: 6.44% C: 6.14%
NVAX | $3.99 2.57% 2.51% 2.9M

|

Health Technology

| -97.33% | O: 7.21% H: 8.92% C: 8.08%
covid india vaccine merge covid-19 emergency use authorization

Gainers vs Losers

67%

33%

Top 10 Gainers

GBR | $1.42 31.48% 11.27% 990K

|

Energy Minerals

KUKE | $2.88 2.49% 7.64% 360K

|

CXM 4 | $11.34 -0.44% 4.27% 1.7M

|

RNR 4 | $224.74 0.85% 3.52% 310K

|

BSBR | $5.25 2.54% 0.38% 430K

|

DV | News | $29.43 -2.36% 0.24% 1.9M

|

JOE 4 | $54.88 1.22% 0.22% 210K

|

JEF 4 | $42.17 1.57% 0.07% 1.8M

|

MUSA 4 | $417.23 1.06% 0.01% 170K

|

JBI 4 | $15.14 1.34% 0.0% 2.9M

|

Your saved searches

Save your searches and get alerts when important news are released.